1a1p
COMPSTATIN, NMR, 21 STRUCTURES
|
OverviewOverview
The third component of complement, C3, plays a central role in activation, of the classical, alternative, and lectin pathways of complement, activation. Recently, we have identified a 13-residue cyclic peptide, (named Compstatin) that specifically binds to C3 and inhibits complement, activation. To investigate the topology and the contribution of each, critical residue to the binding of Compstatin to C3, we have now, determined the solution structure using 2D NMR techniques; we have also, synthesized substitution analogues and used these to study the, structure-function relationships involved. Finally, we have generated an, ensemble of a family of solution structures of the peptide with a hybrid, distance geometry-restrained simulated-annealing methodology, using, distance, dihedral angle, and 3J(NH-Halpha)-coupling constant restraints., The Compstatin structure contained a type I beta-turn comprising the, segment Gln5-Asp6-Trp7-Gly8. Preference for packing of the hydrophobic, side chains of Val3, Val4, and Trp7 was observed. The generated structure, was also analyzed for consistency using NMR parameters such as NOE, connectivity patterns, 3J(NH-Halpha)-coupling constants, and chemical, shifts. Analysis of Ala substitution analogues suggested that Val3, Gln5, Asp6, Trp7, and Gly8 contribute significantly to the inhibitory activity, of the peptide. Substitution of Gly8 caused a 100-fold decrease in, inhibitory potency. In contrast, substitution of Val4, His9, His10, and, Arg11 resulted in minimal change in the activity. These findings indicate, that specific side-chain interactions and the beta-turn are critical for, preservation of the conformational stability of Compstatin and they might, be significant for maintaining the functional activity of Compstatin.
About this StructureAbout this Structure
1A1P is a Protein complex structure of sequences from [1] with NH2 as ligand. Full crystallographic information is available from OCA.
ReferenceReference
Solution structure of Compstatin, a potent complement inhibitor., Morikis D, Assa-Munt N, Sahu A, Lambris JD, Protein Sci. 1998 Mar;7(3):619-27. PMID:9541394
Page seeded by OCA on Sat Nov 24 22:17:32 2007